ArticleCancer medicine2021

First-line nab-paclitaxel plus carboplatin for patients with advanced non-small cell lung cancer: Results of the NEPTUN study.

Tobias Dechow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.